224 related articles for article (PubMed ID: 12518110)
21. Easy, accurate and reliable screening for SNPs by ion pair/reverse phase HPLC: simultaneous detection of factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T variants.
Neitzel B; Matern C; Holinski-Feder E
Clin Lab; 2003; 49(7-8):313-8. PubMed ID: 12908731
[TBL] [Abstract][Full Text] [Related]
22. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
Coulam CB; Wallis D; Weinstein J; DasGupta DS; Jeyendran RS
Am J Reprod Immunol; 2008 Nov; 60(5):426-31. PubMed ID: 18803625
[TBL] [Abstract][Full Text] [Related]
23. Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation.
Pereboom IT; Adelmeijer J; van der Steege G; van den Berg AP; Lisman T; Porte RJ
Transplantation; 2011 Sep; 92(5):587-93. PubMed ID: 21836539
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
Ozmen F; Ozmen MM; Ozalp N; Akar N
Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
[TBL] [Abstract][Full Text] [Related]
25. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis.
Ozyurek E; Balta G; Degerliyurt A; Parlak H; Aysun S; Gürgey A
Clin Appl Thromb Hemost; 2007 Apr; 13(2):154-60. PubMed ID: 17456624
[TBL] [Abstract][Full Text] [Related]
26. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
[TBL] [Abstract][Full Text] [Related]
27. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
Glueck CJ; Wang P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
[TBL] [Abstract][Full Text] [Related]
28. Prothrombotic genetic risk factors in young survivors of myocardial infarction.
Ardissino D; Mannucci PM; Merlini PA; Duca F; Fetiveau R; Tagliabue L; Tubaro M; Galvani M; Ottani F; Ferrario M; Corral J; Margaglione M
Blood; 1999 Jul; 94(1):46-51. PubMed ID: 10381497
[TBL] [Abstract][Full Text] [Related]
29. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
[TBL] [Abstract][Full Text] [Related]
30. Frequency of three prothrombotic polymorphisms among Syrian population: factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T.
Jarjour RA; Ammar S; Majdalawi R
Ann Hum Biol; 2017 Feb; 44(1):70-73. PubMed ID: 26560857
[TBL] [Abstract][Full Text] [Related]
31. Factor V Leiden (G1691A), the prothrombin 3'-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): a single genetic test genotypes all three loci--determination of frequencies in the S. Wales population of the UK.
Bowen DJ; Bowley S; John M; Collins PW
Thromb Haemost; 1998 May; 79(5):949-54. PubMed ID: 9609227
[TBL] [Abstract][Full Text] [Related]
32. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
33. Thrombophilic polymorphisms in Israel.
Zoossmann-Diskin A; Gazit E; Peleg L; Shohat M; Turner D
Blood Cells Mol Dis; 2008; 41(2):230-3. PubMed ID: 18583164
[TBL] [Abstract][Full Text] [Related]
34. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the interactions of common genetic mutations in stroke subtypes.
Szolnoki Z; Somogyvári F; Kondacs A; Szabó M; Fodor L
J Neurol; 2002 Oct; 249(10):1391-7. PubMed ID: 12382154
[TBL] [Abstract][Full Text] [Related]
36. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
37. Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss.
Jeddi-Tehrani M; Torabi R; Zarnani AH; Mohammadzadeh A; Arefi S; Zeraati H; Akhondi MM; Chamani-Tabriz L; Idali F; Emami S; Zarei S
Am J Reprod Immunol; 2011 Aug; 66(2):149-56. PubMed ID: 21241403
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
39. Mutations in clotting factors and inflammatory bowel disease.
Bernstein CN; Sargent M; Vos HL; Rosendaal FR
Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
[TBL] [Abstract][Full Text] [Related]
40. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
Gohil R; Peck G; Sharma P
Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
